Aptiom (Sunovion Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Aptiom drug offered from Sunovion Pharmaceuticals Inc.. This Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sunovion Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | ESLICARBAZEPINE ACETATE |
| SUBSTANCE NAME: | ESLICARBAZEPINE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-04-07 |
| END MARKETING DATE: | 0000-00-00 |
Aptiom HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aptiom from Sunovion Pharmaceuticals Inc. |
| LABELER NAME: | Sunovion Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2014-04-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63402-202_dbde4c7c-e9c4-4490-8b50-c682bcc0368b |
| PRODUCT NDC: | 63402-202 |
| APPLICATION NUMBER: | NDA022416 |
Other ESLICARBAZEPINE ACETATE Pharmaceutical Manufacturers / Labelers:
